Macular degeneration other diagnostic studies

Jump to navigation Jump to search

Macular degeneration Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Macular Degeneration from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Macular degeneration other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Macular degeneration other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Macular degeneration other diagnostic studies

CDC on Macular degeneration other diagnostic studies

Macular degeneration other diagnostic studies in the news

Blogs on Macular degeneration other diagnostic studies

Directions to Hospitals Treating Macular degeneration

Risk calculators and risk factors for Macular degeneration other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

Fluorescein angiography allows for the identification and localization of abnormal vascular processes. Optical coherence tomography is now used by most ophthalmologists in the diagnosis and the followup evaluation of the response to treatment by using either Avastin or Lucentis which are injected into the vitreous of the eye at various intervals.

References

Template:WH Template:WS